Yeah---sure----on 8 million shares. You need to get a new day job. Your short paymasters will soon be unable to compensate you your daily gruel. Wait until Monday's XON CC. More fun in store.
I continue to believe that partnering talks likely morph into buyout discussions. QIDP (10 years exclusivity in the US) , the EU lawsuit(s) plus the accrued tax losses make this too sweet of a prize to pass up. We will be waving bye by April.
Options Expiry today. Lots of 10s and 11s O/S. They will let this breath next week.
Settle now or deal with CRMD's partner/acquirer. The BIG BOYS will take no prisoners. Elliot will add their immense weight to the festivities. CLOCK IS TICKING......
I think I see some flatbeds pulling up.
we get some solid news this AM. Whatever it is, Elliot is somehow in the mix. The Tauro-Trio better check that their BMWs are still in their collective driveways. Perhaps said vehicles are already loaded on a (formerly) Argentine vessel heading for points unknown. The USS Paul Singer---full steam ahead.
This is not a management problem. Nothing can be done about the general level of metals pricing. If all in costs(labor, materials, energy etc.) are X and selling price for output is below X they are stuck for the foreseeable future. At least management is trying to get its balance sheet back into some semblance of order. The financings of the last few years would have made sense if metals prices stayed up. In hindsight , it was a steep price to pay to develop Milligan.
I guess fuel oil and fertilizer should be banned as well. Bas --not to mention box cutters. You are silly.
That is why I love the better boards. Regular folks get to gang tackle investment ideas and dig together. This is a pretty good board in that very few trolls have arrived. That said, I prefer Investor Village because it is easier to post links and longer content. Yahoo has lost much of its original functionality.
Right, Kirk's Tanks are cresting the hill right now preparing to roll over the shorts. Are they called shorts based upon some anatomical feature?
e. The interesting next show is what (if anything ) will Taurpharm do? Possibilities include:
1) Fight both lawsuits until the bitter end and let the chips fall where they may
2) Sit on their hands to see if CRMD can ink a U.S partner
3) Come to the table and negotiate
The risk for Tauropharm is if they lose, they lose in a big way. Injunctions, claw backs etc . would be catastrophic. Waiting to see if CRMD inks a partner is also quite dangerous since a U.S. deal with a major could include an EU aspect. At that point negotiation may be moot because the U.S. trial partner may decide to storm fortress EU and the ultimate disposition of the lawsuit is less important since the sheer number of boots on the ground and legal resources of a multinational would overwhelm the 3 German Amigos.
Negotiation is an interesting possibility. Perhaps TP seeks to maintain global manufacturing rights to the combined EU/US sales in return for an equity split. Remember, TP has no way of ever entering the U.S market. Also, the lawsuit likely means that the sale value of TP's "Almost Neutrolin" franchise to a third party is close to nil---it is equivalent to trying to sell a house you are squatting in when you don't have a deed.
Becton, ABT, BAX on the supply front. Any number of companies from Amgen to KERX in the drug space. This is a catheter care product NOT simply a dialysis bet so I doubt DaVita of Fresenius.
Guys- Elliot is not selling this company for 30-40% up. That is an absurdly low valuation if you think the drug has ANY chance of garnering approval. 10 years of exclusivity is worth much more. There is very little in the way of competitive threats in the U.S. catheter lock space.
As an ZIOP long for 8 years I could not agree more with your sentiment. Kirk could have bought the whole thing @ $3 a share post the Pali failure and owned 100% of his cancer rights. Instead, he took the high road. RJK is an extraordinary leader and a visionary.
It was VERY interesting to hear Bill Miller on the roadshow call yesterday. I think he has come to play in ZIOPville in a big way. Don't be surprised if other prominent funds pop up in filings over the coming weeks. Word is that all questionable players got ZERO in the offering. Deal was oversubscribed 2.5X. My bet is Fidelity took a chunk. This should go higher over the coming "days/weeks/months" (That phrase sounds familiar???).
Well, options market seems to be pointing to a Feb. event . We will know if the close-in call buyers are correct in about 20 days. If Kirk did truly "leap frog" the other players in the space, this could get silly. Science appears validated now we need to see someone step up with a check book.
The real question in a partner is what does Kirk need. Many can provide funding but I suspect he is seeking funding plus some expertise or IP that would be accretive to the XON-ZIOP-MDA Immuno-Oncology Triumvirate.